Related Experiment Video

Updated: Jul 21, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative

M Venturini1, A Zanca1, A Venturuzzo1

  • 1Dermatology Department, University of Brescia, ASST Spedali Civili Hospital, Brescia, Italy.

Journal of the European Academy of Dermatology and Venereology : JEADV
|November 1, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

717

Related Experiment Videos

Last Updated: Jul 21, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

717

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Articles linked to this work by shared authors, journal, and citation graph.

A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome.

International journal of dermatology·2026

Clinical and Functional Determinants of Caregiver Burden in Elderly Patients with Atopic Dermatitis: A Multicentre Cross-Sectional Study.

Clinical, cosmetic and investigational dermatology·2026

Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

Clinical proteomics·2026

Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management.

Journal of clinical medicine·2026

Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Dermatology and therapy·2026

Real-World Experience of Guselkumab in the Elderly Population.

Psoriasis (Auckland, N.Z.)·2026

Factors influencing quality of life in hidradenitis suppurativa: Data from 1188 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Male genital lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

A step forward in hidradenitis suppurativa consultations: The development of conversation cards.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Hair transplantation for secondary cicatricial alopecia: A Chinese expert consensus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Consensus on energy-based devices for keloids and hypertrophic scars: A Latin American Delphi study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)-VK4-116, as a Non-Opioid Medication for the Treatment of Opioid Use Disorder.

Medicinal research reviews·2026

Benzodiazepine Withdrawal Masked by Clonidine: An Emergency Presentation With a Diagnostic Challenge.

Substance use & addiction journal·2026

Beyond control in psychiatric research: systematic review and meta-analysis of placebo treatment responses across major psychiatric conditions in citalopram and escitalopram RCTs.

The British journal of psychiatry : the journal of mental science·2026

Health Harms Associated With Forced Displacements Among People Who Use Drugs in San Francisco, California.

Substance use & addiction journal·2026

Curation and Extraction of Drug-Related Entities from Reddit Platform.

Proceedings. IEEE International Conference on Healthcare Informatics·2026

Opioid-sparing and opioid-free anaesthesia: concepts, rationale, evidence, and practical implications.

Anaesthesiology intensive therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us